Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-Coated Balloon Angioplasty in Patients Undergoing Complex Percutaneous Coronary Intervention.
Joh HS, Kwon W, Shin D, Lee SH, Hong YJ, Hong D, Lee SY, Park H, Kim S, Lee SY, Koh JS, Kim H, Kim CJ, Choo EH, Yoon HJ, Park SD, Jeon KH, Bae JW, Ahn SG, Kim SE, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM. Joh HS, et al. Among authors: lee sh, lee sy, lee jm. JACC Asia. 2024 Jun 18;4(7):519-531. doi: 10.1016/j.jacasi.2024.04.007. eCollection 2024 Jul. JACC Asia. 2024. PMID: 39101114 Free PMC article.
The efficacy and safety of mechanical hemodynamic support in patients undergoing high-risk percutaneous coronary intervention with or without cardiogenic shock: Bayesian approach network meta-analysis of 13 randomized controlled trials.
Lee JM, Park J, Kang J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Kim SH, Kim HS. Lee JM, et al. Among authors: lee se. Int J Cardiol. 2015 Apr 1;184:36-46. doi: 10.1016/j.ijcard.2015.01.081. Epub 2015 Jan 29. Int J Cardiol. 2015. PMID: 25697869
Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.
Lee JM, Park J, Kang J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS. Lee JM, et al. Among authors: lee se. JACC Cardiovasc Interv. 2015 Mar;8(3):382-394. doi: 10.1016/j.jcin.2014.09.023. Epub 2015 Feb 18. JACC Cardiovasc Interv. 2015. PMID: 25703886 Free article.
Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Lee JM, Hahn JY, Kang J, Park KW, Chun WJ, Rha SW, Yu CW, Jeong JO, Jeong MH, Yoon JH, Jang Y, Tahk SJ, Gwon HC, Koo BK, Kim HS. Lee JM, et al. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1318-1331. doi: 10.1016/j.jcin.2015.05.014. JACC Cardiovasc Interv. 2015. PMID: 26315734 Free article.
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
Lee JM, Jung JH, Park KW, Shin ES, Oh SK, Bae JW, Rhew JY, Lee N, Kim DB, Kim U, Han JK, Lee SE, Yang HM, Kang HJ, Koo BK, Kim S, Cho YK, Shin WY, Lim YH, Rha SW, Kim SY, Lee SY, Kim YD, Chae IH, Cha KS, Kim HS. Lee JM, et al. Among authors: lee sy, lee n, lee se. Trials. 2015 Sep 15;16:409. doi: 10.1186/s13063-015-0925-5. Trials. 2015. PMID: 26374625 Free PMC article. Clinical Trial.
Long-Term Clinical Outcomes of Fractional Flow Reserve-Guided Versus Routine Drug-Eluting Stent Implantation in Patients With Intermediate Coronary Stenosis: Five-Year Clinical Outcomes of DEFER-DES Trial.
Park SH, Jeon KH, Lee JM, Nam CW, Doh JH, Lee BK, Rha SW, Yoo KD, Jung KT, Cho YS, Lee HY, Youn TJ, Chung WY, Koo BK. Park SH, et al. Among authors: lee bk, lee hy, lee jm. Circ Cardiovasc Interv. 2015 Dec;8(12):e002442. doi: 10.1161/CIRCINTERVENTIONS.115.002442. Circ Cardiovasc Interv. 2015. PMID: 26643736 Clinical Trial.
Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Song PS, Song YB, Lee JM, Hahn JY, Choi SH, Choi JH, Lee SH, Park KW, Kim HS, Jang Y, Seung KB, Oh JH, Gwon HC. Song PS, et al. Among authors: lee sh, lee jm. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1879-86. doi: 10.1016/j.jcin.2016.06.049. Epub 2016 Aug 31. JACC Cardiovasc Interv. 2016. PMID: 27592016 Free article.
Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes (SMART-DATE) prospective multicenter randomized trial.
Lee JM, Cho DK, Hahn JY, Song YB, Park TK, Oh JH, Lee JB, Doh JH, Kim SH, Yang JH, Choi JH, Choi SH, Lee SH, Gwon HC. Lee JM, et al. Among authors: lee sh, lee jb. Am Heart J. 2016 Dec;182:1-8. doi: 10.1016/j.ahj.2016.07.022. Epub 2016 Aug 26. Am Heart J. 2016. PMID: 27914488 Clinical Trial.
Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM, Rhee TM, Hahn JY, Hwang D, Park J, Park KW, Kim HL, Kim SH, Chae IH, Doh JH, Jeon KH, Choi YJ, Park JS, Choi SH, Gwon HC, Koo BK, Alfonso F, Kim HS. Lee JM, et al. Int J Cardiol. 2017 Mar 1;230:181-190. doi: 10.1016/j.ijcard.2016.12.176. Epub 2016 Dec 29. Int J Cardiol. 2017. PMID: 28043660
7,168 results